ARCHIVES

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

This article is from The Cancer Letter archive.

Vol. 34 No. 38 | October 17, 2008

Download PDF Visit The Full Archive

Related Articles

Breast-Conserving Procedures Lead To Frequent Follow-up Care

April 27, 2012

In Brief: Lobuglio Named Alabama Comprehensive Center Director; NCI FY 1983 Funds Will Be $983.6 Million

January 7, 1983

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009

The Avastin Story In A Nutshell: A Timeline

May 27, 2011

In Brief: NCI To Go Along With NCAB on Keeping Clinical Education Program Alive; Cal Baldwin Retires

February 28, 1986

HHS Carcinogen Guidelines Draft

June 6, 1980